European pharma 'risks being left behind'
Share - WeChat
The chief of the European Medicines Agency, or EMA, says unpredictability over policy in the United States means regional authorities must work together more closely or risk missing out on benefiting from advances in treatment.
Most Viewed in 24 Hours



























